Literature DB >> 12800809

Alternative therapies: a common practice among men and women living with HIV.

Cheryl Gore-Felton1, Mark Vosvick, Rachel Power, Cheryl Koopman, Eric Ashton, Michael H Bachmann, Dennis Israelski, David Spiegel.   

Abstract

This study examined the prevalence and factors associated with alternative therapy use in an ethnically diverse, gender-balanced sample of persons living with HIV/AIDS. More than two thirds (67%) of the participants who were taking HIV-related medications were also taking an alternative supplement. Half of the sample (50%) reported that they took one or more multivitamins, 17% reported using mineral supplements, 12% reported using Chinese herbs, and 12% reported using botanicals. Substantial proportions of the sample also reported using acupuncture (31%), massage (23%), and meditation (28%) to specifically treat HIV-related symptoms. Women were four times more likely to use alternative therapies than men. Also, Caucasians were nearly four times more likely to use alternative treatments compared to other ethnic groups. The results of this study indicate a strong need to assess individual patients' use of alternative treatment approaches as well as to further investigate their efficacy among HIV-positive patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12800809     DOI: 10.1177/1055329003014003002

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  11 in total

Review 1.  A review of the use of complementary and alternative medicine and HIV: issues for patient care.

Authors:  Ava Lorenc; Nicola Robinson
Journal:  AIDS Patient Care STDS       Date:  2013-09       Impact factor: 5.078

Review 2.  Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care.

Authors:  Rae A Littlewood; Peter A Vanable
Journal:  AIDS Care       Date:  2008-09

3.  Use of complementary and alternative medicine for treatment among African-Americans: a multivariate analysis.

Authors:  Jamie C Barner; Thomas M Bohman; Carolyn M Brown; Kristin M Richards
Journal:  Res Social Adm Pharm       Date:  2010-09

4.  Pharmacokinetic enhancers (cobicistat/ritonavir) and the potential for drug-drug interactions.

Authors:  Paul Hollywood; Rachel MacCann; David Lorigan; Eoghan de Barra; Samuel McConkey
Journal:  Ir J Med Sci       Date:  2019-11-18       Impact factor: 1.568

5.  Acu/Moxa for distal sensory peripheral neuropathy in HIV: a randomized control pilot study.

Authors:  Joyce K Anastasi; Bernadette Capili; Donald J McMahon; Colin Scully
Journal:  J Assoc Nurses AIDS Care       Date:  2013 May-Jun       Impact factor: 1.354

Review 6.  Ginseng compounds: an update on their molecular mechanisms and medical applications.

Authors:  Jian-Ming Lü; Qizhi Yao; Changyi Chen
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

Review 7.  Massage therapy for people with HIV/AIDS.

Authors:  Susan L Hillier; Quinette Louw; Linzette Morris; Jeanine Uwimana; Sue Statham
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

8.  Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infection.

Authors:  Felise B Milan; Julia H Arnsten; Robert S Klein; Ellie E Schoenbaum; Galina Moskaleva; Donna Buono; Mayris P Webber
Journal:  AIDS Patient Care STDS       Date:  2008-10       Impact factor: 5.078

9.  Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda.

Authors:  Betty Namuddu; Joan N Kalyango; Charles Karamagi; Peter Mudiope; Samwel Sumba; Henry Kalende; Eric Wobudeya; Brian K Kigozi; Paul Waako
Journal:  BMC Public Health       Date:  2011-11-10       Impact factor: 3.295

10.  Inhibition of HIV-1 entry by extracts derived from traditional Chinese medicinal herbal plants.

Authors:  In-Woo Park; Changri Han; Xiaoping Song; Linden A Green; Ting Wang; Ying Liu; Changchun Cen; Xinming Song; Biao Yang; Guangying Chen; Johnny J He
Journal:  BMC Complement Altern Med       Date:  2009-08-05       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.